04:48 PM EDT, 05/26/2026 (MT Newswires) -- Assembly Biosciences ( ASMB ) said late Tuesday it has closed its underwritten offering of more than 3.9 million shares at $26.50 apiece, including the full exercise of an over-allotment option.

The company also said it sold to an existing investor pre-funded warrants to buy up to 415,000 shares.

Gross proceeds of about $115 million will be used to fund clinical development and for general corporate purposes, it said.